Both in Biotechnology
Gilead Sciences vs Exelixis
Over the past year GILD returned +42.5% and EXEL returned +79.4%; their daily moves had a correlation of 0.35.
GILD +42.5% EXEL +79.4%Growth of $1, one year, split-adjusted
| Metric | GILD | EXEL |
|---|---|---|
| Price | $170.68 | $69.39 |
| Market cap | $211.70B | $16.93B |
| Today | +3.06% | +4.82% |
| 1 month | +15.7% | +19.8% |
| 6 months | +29.6% | +58.9% |
| Year to date | +39.1% | +58.3% |
| 1 year | +44.0% | +76.0% |
| Revenue growth (YoY) | +6.8% | +10.2% |
| Gross margin | 81.1% | 96.0% |
| Net margin | 29.3% | 33.1% |
| P/E (TTM) | — | 19.1× |
| Price / sales | 6.8× | 6.8× |
| Net cash | -$19.79B | $892.0M |
| Dividend yield | 1.92% | — |
| Volatility (60d) | 25.5% | 27.5% |
| Short % of float | 1.6% | 11.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).